From: Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands
Varicella (n = 89) | n | (%) | Herpes zoster (n = 119) | n | (%) |
---|---|---|---|---|---|
Neurologic complications | Â | Neurologic complications | Â | ||
Meningitis | 1 | (1.1%) | Meningitis | 1 | (0.8%) |
Cerebrellitis | 1 | (1.1%) | Cerebellitus | 1 | (0.8%) |
Bells palsy | 1 | (1.1%) | Postherpetic neuralgia | 4 | (3.4%) |
Convulsions | 7 | (7.9%) | Trigeminal neuralgia | 3 | (2.5%) |
Headache | 1 | (1.1%) | Bells palsy | 1 | (0.8%) |
Ataxia | 1 | (1.1%) | Facial palsy | 7 | (5.9%) |
Cutaneous complications | Â | Neurological pain | 10 | (8.4%) | |
Skin superinfections | 16 | (18%) | Herpes zoster oticus | 1 | (0.8%) |
Cellulitis | 2 | (2.2%) | Ocular complications | Â | |
Phlegmon | 1 | (1.1%) | Herpes zoster ophthalmicus (not specified) | 20 | (16.8%) |
Abscess | 1 | (1.1%) | Conjunctivitis | 3 | (2.5%) |
Impetigo (secondary) | 2 | (2.2%) | Keratitis | 4 | (3.4%) |
Scar tissue | 3 | (3.4%) | Visus | 5 | (4.2%) |
Complications due to systemic bacterial infections | Â | Cutaneous complications | Â | ||
Osteomyelitis | 1 | (1.1%) | Herpes zoster dermatome | 45 | (37.8%) |
Pyogen artritis | 1 | (1.1%) | Cellulitis | 1 | (0.8%) |
Sepsis | 1 | (1.1%) | Pyoderm | 1 | (0.8%) |
Respiratory tract complications | Â | Cutaneous pain | 1 | (0.8%) | |
Pneumonia | 11 | (12.4%) | Skin superinfections | 2 | (1.7%) |
Bronchitis (acute) | 1 | (1.1%) | Other complications | Â | |
Upper resperatory tract infection (not specified) | 2 | (2.2%) | Pneumonia | 5 | (4.2%) |
Tonsillitis | 2 | (2.2%) | Thrombocytopenia | 1 | (0.8%) |
Lymphadenitis | 3 | (3.4%) | Sepsis | 1 | (0.8%) |
Pharyngitis | 1 | (1.1%) | Â | Â | Â |
Other complications | Â | Â | Â | Â | |
Stomatitis | 3 | (3.4%) | Â | Â | Â |
Hemorrhagic varicella | 1 | (1.1%) | Â | Â | Â |
Fever (extremely high temperature) | 3 | (3.4%) | Â | Â | Â |
Dehydration | 13 | (14.6%) | Â | Â | Â |
Thrombocytopenia | 1 | (1.1%) | Â | Â | Â |
Anemia | 1 | (1.1%) | Â | Â | Â |
Extreme varicella (not specified/unknown complications) | 5 | (5.6%) | Â | Â | Â |